Interestingly, the cells do not immediately shrink after stimulation of the CD95 receptor.
T he maintenance of an adequate cell number requires a delicate balance between cell proliferation and cell death. This balance allows the optimal adaptation to ever-changing functional needs. For instance, proper function of the immune system requires rapid increase of lymphocyte number upon infection and their subsequent removal after recovery.
Cell death may be accomplished by at least two distinct mechanisms, necrosis and apoptosis. Necrosis is an a priori pathophysiological mechanism involving cell swelling and disruption of the cell membrane with release of intracellular proteins leading to immune response and subsequent inflammation. Among the hallmarks of apoptosis are cell shrinkage, nuclear condensation, DNA fragmentation, and a rearrangement of the cell membrane with exposure of phosphatidylserine residues at the extracellular surface (10) . Eventually, the cell is decomposed into small particles that are readily taken up by macrophages. Usually, no intracellular proteins are released from the apoptotic cell, and thus inflammation is avoided.
Apoptosis serves not only in adjusting the cell number of any given tissue to the respective functional demand but also in accomplishing the removal of cells during embryogenesis and metamorphosis. Moreover, apoptosis allows the elimination of tumor cells, infected cells, and autoreactive lymphocytes (10) .
Although apoptosis is a physiological mechanism, both defective and excessive apoptosis may lead to serious disease. Although defective apoptosis may account for the development of tumors and excessive function such as enhanced hormone production or autoimmune disease, excessive apoptosis may result in defective function such as neurodegeneration or immunodeficiency (10) .
Important causes of necrosis include energy depletion and physical damage. Apoptosis may be triggered by a wide variety of stimuli including bacterial toxins, radiation, gross increase of extracellular osmolarity, oxidative stress, c-Myc overexpression, growth factor depletion, glucocorticoids, and the stimulation of certain cell membrane receptors, such as the tumor necrosis factor (TNF) receptor or the CD95(Fas/Apo-1) receptor. Tissue injury such as ischemia may trigger apoptosis through upregulation of the respective receptors and ligands. Thus the cells may be removed by apoptosis before necrosis and inflammation thereby avoided (10) .
This brief review outlines cellular mechanisms triggered by stimulation of the CD95 receptor in lymphocytes. The CD95 receptor may not only confer apoptosis. Thus not all events triggered by the CD95 receptor necessarily serve apoptosis, and the relevance of each mechanism for apoptosis must be verified. Even though we are still far from understanding the mechanisms eventually leading to apoptotic cell death, considerable progress has been made within the past few years in disclosing the involvement of intracellular signaling molecules as well as ion channels and transporters in the cell membrane. Here we focus on CD95-induced apoptosis of Jurkat T lymphocytes. Special emphasis will be placed upon the role of transport mechanisms at the cell membrane. For more detailed information on other aspects of apoptotic cell death, the reader may consult a recent collection of reviews (10) .
Signaling of the CD95(Fas/Apo-1) receptor
The CD95 receptor belongs to the TNF/nerve growth factor (NGF) family of receptors. Its ligand, the CD95(Fas/Apo-1) ligand (CD95L), is (13), a cysteine protease cleaving proteins after aspartic acid (10) . This complex has been named the death-inducing signal complex (DISC). Upon formation of the complex, the activation signal is transferred to further proteins including several sphingomyelinases, which cleave sphingomyelin to ceramide. Ceramide has been implied to be involved in the regulation of Jun N-terminal kinase, Rafkinase, Bad, Src-like tyrosine kinase Lck 56 , the G proteins Ras and Rac, and p38 kinase, as well as formation of O 2 -(3, 4, 10, 13). Furthermore, activation of the CD95 receptor or cellular treatment with ceramide stimulates the release of cytochrome c from mitochondria (13) . Cytochrome c associates with several cytosolic proteins, resulting in the stimulation of further caspases (10) . In the terminal phase, nuclear endonucleases are activated. Apparently, a second pathway activated by the CD95 receptor leads, through regulation of caspases and p21-activated kinase (PAK) kinase, to translocation of phosphatidylserine to the outer surface of the cell membrane, allowing the binding of annexin.
The significance of most signaling elements for the apoptotic outcome has been shown by both pharmacological and genetic knockout experiments. For instance, inhibition of caspase 8 or caspase 3 prevents CD95-triggered death. Likewise, CD95-induced lymphocyte apoptosis is delayed by a deficiency in sphingomyelinase or Lck 56 and restored by transfection of the deficient cells with the respective genes (1, 3, 4) . Inhibition or genetic knockout of either p38 kinase or Jun kinase alone does not abolish CD95-induced apoptosis, but simultaneous knockout of both kinases prevents CD95-induced apoptosis (1) .
Apoptosis is negatively regulated by several proteins, including members of the Bcl 2 protein family (10) . Thus Bcl xl and Bcl 2 prevent most forms of apoptosis. On the other hand, further members of the Bcl 2 protein family, in particular Bad and Bax, promote cell death. The mode of action of these proteins is not yet clear. In lipid bilayers, Bcl 2 forms ion channels, which has been taken as evidence that Bcl 2 may function as an ion channel in the mitochondrial membrane (10) . However, conclusive evidence is still missing that Bcl 2 indeed serves as a channel in vivo. Nevertheless, Bcl 2 has been shown to inhibit cytochrome c release from mitochondria.
Activation of the anion channel ORCC and cytosolic acidosis
Stimulation of the CD95 receptor is followed by activation of the outwardly rectifying chloride channel (ORCC) within minutes (Fig. 1) One of the sequelae of ORCC activation is cytosolic acidosis (Fig. 1) , which may be important for the induction of cell death. Inhibition of the channel and/or the Lck 56 reduces CD95-induced cytosolic acidosis. Moreover, these maneuvers impede CD95-induced DNA fragmentation and annexin binding, pointing to the functional importance of ORCC activation for apoptosis (15) . However, because the available ORCC inhibitors are not very selective for this channel and the gene encoding the channel is still elusive, specific knockout of the channel is not possible and the exact role of ORCC in the apoptotic machinery remains to be shown. Beyond that, cytosolic acidification and apoptosis are not completely abolished by the chloridechannel blockers, pointing to the involvement of additional mechanisms.
Lck 56 is activated and stimulates ORCC not only after CD95-receptor triggering but also during osmotic cell swelling (8) . Pharmacological or genetic knockout of Lck 56 prevents swellinginduced activation of ORCC as well as cell volume regulation. Thus activation of the CD95 receptor mimics the effect of osmotic cell swelling on Lck 56 and ORCC.
Instead, they maintain a constant volume for up to 45 min (6) . The failure of the cells to shrink may be at least partially due to inhibition of Kv1.3 ( Fig. 2) , the cell volume regulatory K + channel of Jurkat lymphocytes. Similar to the activation of ORCC, the inhibition of Kv1.3 requires Lck 56 (4, 14) . Moreover, the channel protein is tyrosine phosphorylated upon CD95-receptor stimulation, an effect abolished in cells lacking Lck 56 (4, 14) . On the other hand, Kv1.3 is activated by cell swelling despite simulation of Lck 56 , pointing to further mechanisms of channel regulation.
Besides its effect on cell volume, inhibition of Kv1.3 favors depolarization of the cell membrane, which may similarly contribute to apopto- + channels has been shown to foster (9) and activation of K + channels to inhibit (7) apoptosis in other cells. Moreover, activation of K + channels leading to hyperpolarization is one of the key events paralleling cell proliferation (2, 11) . However, inhibition of K + channels has been shown to stimulate or inhibit apoptotic cell death, and the role of K + channels in apoptotic cell death is still far from understood.
Release of taurine
Possibly because of the opposing effects of ORCC activation and Kv1.3 inhibition, cell volume remains virtually constant within the first 45 min of CD95-receptor stimulation. At this time, a marked release of the osmolyte taurine is observed (Fig. 3) . Taurine release and apoptotic cell shrinkage are immediately followed by DNA fragmentation. The taurine release is not caused by nonspecific leakage of the cell membrane, because the amino acid leucine is not released after CD95-receptor triggering. However, other osmolytes are possibly released in parallel. Several chloride channel inhibitors [5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), glibenclamide, 3Ј-azido-3Ј-deoxythymidine (AZT), tamoxifen] failed to inhibit CD95-induced taurine release (6) . The differences in the time course of activation and inhibitor sensitivity indicate that the mechanism of CD95-induced taurine release is distinct from ORCC. CD95-induced taurine release is blunted by lowering the temperature to 23°C. If the cells are stimulated by CD95 at 23°C and rewarmed to 37°C after 90 min, taurine is released within a few minutes, indicating that the mechanism accounting for the delay of taurine release is not temperature sensitive. Interestingly, CD95-induced cell shrinkage and DNA fragmentation show temperature sensitivity similar to that of taurine release, i.e., the cells do not undergo cell shrinkage or DNA fragmentation after CD95 receptor stimulation at 23°C. However, rewarming after 90 min leads to rapid cell shrinkage and DNA fragmentation. These observations point to a functional link between osmolyte release, apoptotic cell News Physiol. Sci.
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The interaction of cell volume and apoptosis
As mentioned above, a doubling of osmolarity may by itself trigger apoptosis (12) . Evidence has been presented that osmotic cell shrinkage leads to clustering of TNF receptors, which allows ligand-independent activation of the postreceptor events (12) . The significance of cell volume in apoptosis has further been documented by the observation that the volume regulatory ability of cells correlates with their ability to resist hypertonicity-induced apoptosis (5) . Surprisingly, though, we observed an inhibition of CD95-induced DNA fragmentation after moderate (100 mM NaCl) increase of extracellular osmolarity (5) . The inhibition of DNA fragmentation was paralleled by a decrease of O 2 -formation, as reflected by the concentration of reduced glutathione. As osmotic cell shrinkage inhibits flux of glucose through the pentose shunt pathway (5), the effect on O 2 -formation could have been caused by decreased availability of NADPH for NADPH oxidase. Along these lines, osmotic cell shrinkage inhibits the oxidative burst in leukocytes (5 
Conclusions and future perspectives
The apoptotic machinery involves a wide variety of signaling molecules, including caspases, ceramide, small G proteins, cytochrome c, tyrosine kinases, PI3 kinase, and MAP kinase pathways (Fig. 4) . Most recently, the active participation of transport processes across the cell membrane has been disclosed, such as K + channels, anion channels, and osmolyte release mechanisms. The involvement of further signaling molecules and transport proteins is more than likely. The inhibition of K + channels, the intracellular acidosis caused by activation of anion channels, and the cell shrinkage, caused at least in part by osmolyte release, mirror opposite events during cell proliferation, such as K + -channel activation, cytosolic alkalosis, and cell volume increase. Ample further evidence points to a major role of the transport processes for the eventual fate of the cells. Nevertheless, considerable additional information is required to fully understand the complex interplay among signaling, transport, as well as cell volume on the one side and DNA fragmentation, proteolysis, as well as translocation of phosphatidylserine in the cell membrane on the other. We hope that this brief review stimulates further experimental effort to unravel the fascinating machinery leading to apoptotic cell death. 
